Table 5 Laboratory findings of studied groups
From: Serum Krebs von den Lungen (KL-6) level as a marker of exacerbation of interstitial lung diseases
Group I (stable), N = 26 | Group II (exacerbation), N = 47 | Group III (healthy control), N = 15 | P value | |||
|---|---|---|---|---|---|---|
Mean ± SD, Range | Mean ± SD, Range | Mean ± SD, Range | Group I and II | Group I and III | Group II and III | |
WBCs (×103/μL) | 7.28 ± 2.08, 4–11 | 9.85 ± 2.68, 3.8–15 | 7.34 ± 1.88, 4.9–10.7 | < 0.001 | 0.940 | 0.002 |
ESR1 (mm/h) | 24.34 ± 26.20, 5–100 | 25.21 ± 23.11, 5–90 | 10.66 ± 8.63, 5–40 | 0.981 | 0.047 | 0.031 |
ESR2 (mm/h) | 43.61 ± 37.81, 10–130 | 43.85 ± 32.07, 10–115 | 21.20 ± 17.28, 10–80 | 0.976 | 0.034 | 0.019 |
CRP (mg/l) | 16.38 ± 44.14, 0–192 | 25.27 ± 25.20, 0–192 | 1.60 ± 3.56, 0–12 | 0.233 | 0.136 | 0.010 |
KL6 (U/ml) | 137.38 ± 34.24, 95–284 | 301.89 ± 67.29, 140–532 | 48.40 ± 11.63, 27–53 | < 0.001 | < 0.001 | < 0.001 |